IL17RA and central nervous system cancer: We have observed, for the first time, preferential co-localization of IL-17RA (referred to as IL-17R in this manuscript) with GSC markers in human primary malignant gliomas, suggesting that IL-17R+ glioma cells may represent a subpopulation of GSCs.